loadpatents
Patent applications and USPTO patent grants for NEWMAN; Roland.The latest application filed is for "bi-specific binding agents targeting syndecan-1 and fibroblast growth factor receptor".
Patent | Date |
---|---|
Bi-specific Binding Agents Targeting Syndecan-1 And Fibroblast Growth Factor Receptor App 20220249679 - CORONELLA; Julia ;   et al. | 2022-08-11 |
CMET monoclonal binding agents, drug conjugates thereof and uses thereof Grant 11,299,547 - Coronella , et al. April 12, 2 | 2022-04-12 |
Syndecan-1 (CD138) binding agents and uses thereof Grant 11,242,403 - Coronella , et al. February 8, 2 | 2022-02-08 |
DRUG CONJUGATES OF cMET MONOCLONAL BINDING AGENTS, AND USES THEREOF App 20210163604 - CORONELLA; Julia ;   et al. | 2021-06-03 |
Syndecan-1 (cd138) Binding Agents And Uses Thereof App 20200181278 - CORONELLA; Julia ;   et al. | 2020-06-11 |
Cmet Monoclonal Binding Agents, Drug Conjugates Thereof And Uses Thereof App 20190330354 - CORONELLA; Julia ;   et al. | 2019-10-31 |
Antibody-fynomer conjugates Grant 10,323,095 - Newman , et al. | 2019-06-18 |
Antibody-fynomer Conjugates App 20170081412 - NEWMAN; Roland ;   et al. | 2017-03-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.